{"id":2627,"date":"2019-10-22T14:06:12","date_gmt":"2019-10-22T18:06:12","guid":{"rendered":"http:\/\/localhost:10028\/whitepapers\/260m-settlement-to-avoid-federal-opioid-trial-in-ohio\/"},"modified":"2022-06-27T02:33:52","modified_gmt":"2022-06-27T06:33:52","slug":"%e5%9b%9e%e9%81%bf%e3%81%99%e3%82%8b%e3%81%9f%e3%82%81%e3%81%ae-260m-%e5%92%8c%e8%a7%a3%e9%80%a3%e9%82%a6%e3%82%aa%e3%83%94%e3%82%aa%e3%82%a4%e3%83%89%e6%b2%bb%e9%a8%93%e3%82%aa%e3%83%8f%e3%82%a4","status":"publish","type":"whitepapers","link":"https:\/\/napolilaw.lemonadestand.org\/ja\/%e7%99%bd%e3%81%84%e7%b4%99\/%e5%9b%9e%e9%81%bf%e3%81%99%e3%82%8b%e3%81%9f%e3%82%81%e3%81%ae-260m-%e5%92%8c%e8%a7%a3%e9%80%a3%e9%82%a6%e3%82%aa%e3%83%94%e3%82%aa%e3%82%a4%e3%83%89%e6%b2%bb%e9%a8%93%e3%82%aa%e3%83%8f%e3%82%a4\/","title":{"rendered":"$260M \u30aa\u30cf\u30a4\u30aa\u5dde\u3067\u306e\u9023\u90a6\u30aa\u30d4\u30aa\u30a4\u30c9\u6cbb\u9a13\u3092\u56de\u907f\u3059\u308b\u305f\u3081\u306e\u548c\u89e3"},"content":{"rendered":"<p>The agreement, reached shortly after midnight and announced Monday morning, settles claims the counties made against large distribution companies AmerisourceBergen, McKesson, the Ohio-based Cardinal Health and drugmaker Teva Pharmaceuticals.<\/p>\n<p>Under the agreement, the three distributors will pay a combined $215 million, while Teva will pay $20 million in cash over between now and 2021. Teva will also donate $25 million in Suboxone, a medication used to treat opioid addiction.<\/p>\n<p>Hunter Shkolnik, a New York lawyer hired to represent Cuyahoga County, said talks to negotiate an end to the two Ohio counties\u2019 cases started up again Sunday.<\/p>","protected":false},"excerpt":{"rendered":"<p>\u771f\u591c\u4e2d\u904e\u304e\u306b\u9054\u3057\u3001\u6708\u66dc\u65e5\u306e\u671d\u306b\u767a\u8868\u3055\u308c\u305f\u3053\u306e\u5408\u610f\u306f\u3001\u5927\u898f\u6a21\u306a\u6d41\u901a\u4f01\u696d\u3067\u3042\u308b AmerisourceBergen\u3001McKesson\u3001\u30aa\u30cf\u30a4\u30aa\u306b\u672c\u62e0\u3092\u7f6e\u304f Cardinal Health\u3001\u304a\u3088\u3073\u88fd\u85ac\u4f1a\u793e\u306e Teva Pharmaceuticals \u306b\u5bfe\u3059\u308b\u90e1\u306e\u8acb\u6c42\u3092\u89e3\u6c7a\u3059\u308b\u3082\u306e\u3067\u3059\u3002\u4e0b\u2026<\/p>","protected":false},"featured_media":0,"menu_order":256,"template":"","whitepaper_category":[75,98,253,254],"whitepaper-source":[160],"class_list":["post-2627","whitepapers","type-whitepapers","status-publish","hentry","whitepaper_category-opioids-litigation","whitepaper_category-ohio-opioid-lawyers","whitepaper_category-opioid-crisis","whitepaper_category-opioid-epidemic","whitepaper-source-cleveland-com"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/ja\/wp-json\/wp\/v2\/whitepapers\/2627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/ja\/wp-json\/wp\/v2\/whitepapers"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/ja\/wp-json\/wp\/v2\/types\/whitepapers"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/ja\/wp-json\/wp\/v2\/whitepapers\/2627\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/ja\/wp-json\/wp\/v2\/media?parent=2627"}],"wp:term":[{"taxonomy":"whitepaper_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/ja\/wp-json\/wp\/v2\/whitepaper_category?post=2627"},{"taxonomy":"whitepaper-source","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/ja\/wp-json\/wp\/v2\/whitepaper-source?post=2627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}